Phase II randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of MLC1501 in patients with stroke: the MLC1501 study Assessing Efficacy in post-STrOke Subjects with mOtor deficits (MAESTOSO) study protocol
一项评估 MLC1501 治疗卒中患者疗效和安全性的 II 期随机、双盲、安慰剂对照试验：MLC1501 研究评估卒中后运动功能障碍患者的疗效 (MAESTOSO) 研究方案
期刊:Stroke and Vascular Neurology
影响因子:4.9
doi:10.1136/svn-2024-003750
Chen, Christopher P L H; Esagunde, Romulo U; Escabillas, Cyrus G; Hiyadan, John Harold; Advincula, Joel M; Co, Christian Oliver C; Collantes, Maria Epifania V; Lao, Annabelle Y; Koh, Yeow-Hoay; De Silva, Deidre Anne; Tham, Carol Huilian; Lokin, Johnny K; Venketasubramanian, Narayanaswamy
